Is Your Paper Ready for The BMJ? Open Review and What Editors Actually Want

BMJ's 50% desk rejection rate is more forgiving than NEJM or The Lancet, but half of all research articles still don't make it to review. Here's what editors are evaluating:

Clinical importance for a generalist medical audience. BMJ's readership is primarily general practitioners, internists, and public health physicians. Research that matters only to one specialty, like a new surgical technique or a subspecialty drug comparison, is typically redirected to a BMJ specialty journal (BMJ Open, BMJ Quality and Safety, etc.).

Study design that matches the question. BMJ's editors are methodologically rigorous. For intervention studies, they expect randomization unless there's a strong justification for a quasi-experimental or observational design. For observational studies, they expect sophisticated confounding control. The abstract alone reveals most design weaknesses, and editors catch them.

Relevance to evidence-based practice. BMJ's editorial identity is rooted in evidence-based medicine. Papers that add to the evidence base for a clinical question, confirm or refute current guidelines, or provide evidence for changing practice are favored. Exploratory studies that raise questions without answering them are less likely to clear the desk.

Originality. BMJ's editors screen for originality at the question level, not just the answer level. If the clinical question has been adequately addressed by prior studies, even a well-executed new study may not pass the desk. Check whether a recent Cochrane review or meta-analysis has already answered your question before submitting.

BMJ allows up to 400 words for structured abstracts, which is more generous than NEJM (250 words) or The Lancet (300 words). The required headings are:

• Objectives: What you set out to determine
• Design: Study type (randomised controlled trial, cohort study, etc.)
• Setting: Where the study was conducted
• Participants: Who was included and key eligibility criteria
• Main outcome measures: Primary and secondary endpoints
• Results: Key findings with effect sizes and confidence intervals
• Conclusions: What the findings mean for practice

The extra word allowance is an advantage, but don't waste it on background. BMJ editors want specificity in every section. Use the space to include exact numbers, effect sizes, and confidence intervals rather than general statements.

Several requirements catch authors off guard:

Patient and public involvement (PPI) statement. BMJ requires a statement describing how patients were involved in the research design, conduct, or reporting. If patients weren't involved, you must explain why. This isn't optional. Missing PPI statements can delay processing.

Reporting checklists. CONSORT for RCTs, STROBE for observational studies, PRISMA for systematic reviews. BMJ checks these rigorously. Missing items in the checklist may trigger desk rejection or return for revision before review.

Data sharing statement. BMJ expects a clear statement about data availability. For clinical trials, individual participant data should be made available. BMJ is one of the journals that takes data sharing commitments seriously and may follow up post-publication.

BMJ Disclosure Form. A journal-specific conflict of interest disclosure form that all authors must complete. It's more detailed than the ICMJE form used by many other journals.

BMJ's review process differs substantially from other top medical journals:

Open review. At least two expert peer reviewers evaluate the manuscript, and their names are disclosed to authors. If the paper is accepted, signed reviews are published alongside it. This creates accountability for reviewers and means that personal attacks, lazy reviews, and unconstructive dismissals are much rarer than at anonymously reviewed journals.

Clinical epidemiology review. A clinical epidemiology editor assesses the study design, statistical methods, and analytical approach. This is similar to NEJM's statistical review but explicitly includes epidemiological methodology alongside statistics.

Patient reviewer. For many papers, BMJ assigns a patient or public reviewer who evaluates the study from a patient perspective. They assess whether the research question matters to patients, whether the outcomes measured are meaningful, and whether the findings are communicated clearly. This can flag issues that clinical experts miss, like outcomes that matter to physicians but not to patients.

BMJ offers an underused option: you can submit your abstract and cover letter before preparing a full manuscript. Editors will evaluate whether the study fits BMJ's scope and signal whether a full submission is worth pursuing.

This is particularly valuable when you're unsure about fit. Preparing a full BMJ submission, with PPI statement, data sharing plan, reporting checklists, and disclosure forms, takes time. Getting a signal from editors before investing that effort can save weeks.

Choose BMJ when your paper addresses a clinical question relevant to general practice or public health, when your study design is strong, and when you want the benefit of open peer review and patient reviewers. BMJ is particularly strong for primary care research, preventive medicine, public health interventions, and evidence-based practice studies.

Choose NEJM when your paper is a large clinical trial with hard endpoints that will directly change specialist or hospital-based practice. NEJM's 21-day median decision time makes it worth trying first for practice-changing trials.

Choose The Lancet when your paper has global health implications, involves research from low- and middle-income countries, or addresses health policy at a population level.

If BMJ itself isn't the right fit, the BMJ publishing group includes several specialty journals:

BMJ Open is a broad, open-access journal with a higher acceptance rate (~45-50%) that publishes methodologically sound research regardless of perceived impact. It's a strong landing spot for well-designed studies that don't meet BMJ's significance threshold.

BMJ Quality and Safety for quality improvement and patient safety research.

BMJ Global Health for global health research, similar in scope to The Lancet Global Health.

Heart for cardiovascular research (impact factor ~7.0).

Gut for gastroenterology and hepatology (impact factor ~24.5).

Thorax for respiratory medicine.

Papers aren't automatically transferred between BMJ journals like the Nature or JAMA cascade systems, but editors may suggest a more appropriate BMJ journal in their rejection letter.

Before submitting to BMJ, ask yourself:

Would a general practitioner find this useful? BMJ's readership includes many primary care physicians. If your finding matters only to hospital-based specialists, consider a specialty journal.

Is your study design appropriate for the question? BMJ's clinical epidemiology editors will scrutinize your methods. Make sure your design is justified and your analysis is sound.

Have you addressed patient involvement? BMJ requires a PPI statement. If you haven't involved patients in your research, have a thoughtful explanation ready for why.

Are you comfortable with open review? Your reviewers' names will be disclosed, and their reviews may be published. This isn't a barrier to submission, but it's worth knowing. It means reviews tend to be more constructive and fair.

Have you completed all reporting checklists? BMJ checks these carefully. Submit them with your manuscript, not as an afterthought.

A Manusights pre-submission review can evaluate whether your paper's clinical significance and methodological rigor match what BMJ editors look for during their initial screening.